4.4 Article

Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes

Journal

ANNALS OF HEPATOLOGY
Volume 17, Issue 5, Pages 871-879

Publisher

MEXICAN ASSOC HEPATOLOGY
DOI: 10.5604/01.3001.0012.3169

Keywords

Alcohol intake; Diabetes; Iron overload; rs11558492; rs1800562

Funding

  1. National Institute of Diabetes and Digestive and Kidney Diseases [1R24DK093433-01]
  2. National Cancer Institute [P30 CA-62203]
  3. Department of Veterans Affairs
  4. NHMRC of Australia
  5. Southern Iron Disorders Center

Ask authors/readers for more resources

Introduction and aim. We sought to identify independent risk factors for cirrhosis in HFE p.C282Y homozygotes in a cross-sectional study. Material and methods. We evaluated 368 p.C282Y homozygotes who underwent liver biopsy and compared characteristics of those with and without cirrhosis. We performed multivariable logistic regression on cirrhosis with: age; sex; race/ethnicity; diabetes; blood pints/units donated voluntarily; erythrocyte pints/units received; iron supplement use; alcohol intake, g/d; body mass index, kg/m(2); swollen/tender 2nd/3rd metacarpophalangeal joints; elevated alanine aminotransferase; elevated aspartate aminotransferase; steatosis/fatty liver; iron removed by phlebotomy, g; and GNPAT p.D519G positivity. Results. Mean age of 368 participants (73.6% men) was 47 +/- 13 (standard deviation) y. Cirrhosis was diagnosed in 86 participants (23.4%). Participants with cirrhosis had significantly greater mean age, proportion of men, diabetes prevalence, mean daily alcohol intake, prevalence of swollen/tender 2nd/3rd metacarpophalangeal joints, mean serum ferritin, elevated alanine aminotransferase, elevated aspartate aminotransferase, and mean iron removed; and significantly fewer mean blood pints/units donated. GNPAT p.D519G positivity was detected in 82 of 188 participants (43.6%). In a multivariable model for cirrhosis, there were four significant positive associations: age (10-y intervals) (odds ratio 2.2 [95% confidence interval 1.5, 3.3]); diabetes (3.3; [1.1, 9.7]); alcohol intake (14 g alcohol drinks/d) (1.5 [1.2, 1.8]); and iron removed, g (1.3 [1.2, 1.4]). There was no statistical evidence of two-way interactions between these variables. Conclusion. In conclusion, cirrhosis in HFE p.C282Y homozygotes is significantly associated with age, diabetes, daily alcohol intake, and iron removed by phlebotomy, taking into account the effect of other variables.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Respiratory System

Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study

Carla Colombo, Gianfranco Alicandro, Mark Oliver, Peter J. Lewindon, Grant A. Ramm, Chee Y. Ooi, Federico Alghisi, Nataliya Kashirskaya, Elena Kondratyeva, Fabiola Corti, Rita Padoan, Irina Asherova, Helen Evans, Isabelle de Monestrol, Birgitta Strandvik, Anders Lindblad

Summary: This study evaluated the difference in the incidence of severe liver disease between cystic fibrosis centers that routinely prescribe ursodeoxycholic acid (UDCA) and those that do not. The results showed that CF patients followed-up in UDCA-prescribing centers did not have a lower incidence of portal hypertension (PH) compared to those followed in centers not prescribing UDCA.

JOURNAL OF CYSTIC FIBROSIS (2022)

Review Biochemistry & Molecular Biology

The biology of mammalian multi-copper ferroxidases

Sheridan L. Helman, Jie Zhou, Brie K. Fuqua, Yan Lu, James F. Collins, Huijun Chen, Christopher D. Vulpe, Gregory J. Anderson, David M. Frazer

Summary: The mammalian multicopper ferroxidases (MCFs), including ceruloplasmin, hephaestin, and zyklopen, play crucial roles in maintaining iron homeostasis in the body. They function in oxidizing, releasing, and absorbing iron ions, and have various physiological functions in different tissues. Apart from their iron-related roles, they also have other physiological functions, although many of them are not well-defined.

BIOMETALS (2023)

Article Cell Biology

Therapeutic potential of macrophage colony-stimulating factor in chronic liver disease

Sahar Keshvari, Berit Genz, Ngari Teakle, Melanie Caruso, Michelle F. Cestari, Omkar L. Patkar, Brian W. C. Tse, Kamil A. Sokolowski, Hilmar Ebersbach, Julia Jascur, Kelli P. A. MacDonald, Gregory Miller, Grant A. Ramm, Allison R. Pettit, Andrew D. Clouston, Elizabeth E. Powell, David A. Hume, Katharine M. Irvine

Summary: Resident and recruited macrophages play a crucial role in the development and proliferation of the liver. Previously, the use of a macrophage colony stimulating factor (CSF1)-Fc fusion protein has been shown to promote hepatocyte proliferation and repair in acute hepatic injury in mice. In this study, the impact of CSF1-Fc on the resolution of advanced fibrosis and liver regeneration was investigated using a toxin-induced model of chronic liver injury and fibrosis in mice. The findings suggest that CSF1-dependent macrophages contribute to both the initiation and resolution of fibrotic injury, and that CSF1-Fc has therapeutic potential in the treatment of human liver disease.

DISEASE MODELS & MECHANISMS (2022)

Article Respiratory System

Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: A 27-year real-life cohort study

Marilisa Baldissera, Peter J. Lewindon, Louise E. Ramm, Gunter F. Hartel, Rita Mattiello, Grant A. Ramm

Summary: This study assessed the impact of liver disease on the survival of children with cystic fibrosis. The results showed that advanced cystic fibrosis-associated liver disease (CFLD) was associated with decreased survival, especially in females with cystic fibrosis.

JOURNAL OF CYSTIC FIBROSIS (2022)

Article Respiratory System

Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis

Diego A. Calvopina, Peter J. Lewindon, Louise E. Ramm, Charlton Noble, Gunter F. Hartel, Daniel H. Leung, Grant A. Ramm

Summary: This study investigated the use of gamma-glutamyl transpeptidase-to-platelet ratio (GPR) as a non-invasive biomarker for detecting liver disease and fibrosis severity in children with CF-associated liver disease (CFLD). The results showed that GPR is a useful diagnostic tool for detecting the presence of CFLD, assessing fibrosis severity, and predicting complications of liver disease.

JOURNAL OF CYSTIC FIBROSIS (2022)

Article Immunology

Hydroxychloroquine Therapy and Serum Immunoglobulin Levels in Women with IgG Subclass Deficiency and Systemic Lupus Erythematosus, Sjogren Syndrome, and Rheumatoid Arthritis: A Retrospective Study

James C. Barton, J. Clayborn Barton, Luigi F. Bertoli

Summary: This study retrospectively evaluated immunoglobulin levels in women with IgG subclass deficiency (IgGSD) who were treated with hydroxychloroquine (HCQ) for systemic lupus erythematosus (SLE), Sjogren syndrome (SS), or rheumatoid arthritis (RA). The results showed that HCQ therapy was not associated with significantly lower IgG, IgG subclass, IgA, or IgM levels in women with IgGSD. However, women with combined subnormal IgG1/IgG3 who took HCQ had higher levels of IgG2.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2022)

Article Parasitology

Synthetic peptides derived from the Schistosoma mansoni secretory protein Sm16 induce contrasting responses in hepatic stellate cells

Jack P. Carson, Mark W. Robinson, Grant A. Ramm, Geoffrey N. Gobert

Summary: Sm16 is a protein released by Schistosoma mansoni that modulates inflammatory responses in host cells. This study suggests a potential role for Sm16 in combating fibrotic liver disease.

EXPERIMENTAL PARASITOLOGY (2022)

Article Biochemistry & Molecular Biology

Estimates of West African Ancestry in African Americans Using Alleles of Iron-Related Genes HJV, SLC40A1, and TFR2

James C. Barton, Howard W. Wiener, Ronald T. Acton

Summary: This study estimated the proportion of West African Black ancestry in African Americans using allele frequencies of iron-related genes, showing that the average proportion of West African Black ancestry in African Americans is 87.8%.

GENETIC TESTING AND MOLECULAR BIOMARKERS (2022)

Article Medicine, General & Internal

Arthritis Prediction of Advanced Hepatic Fibrosis in HFE Hemochromatosis

Lauren Andersson, Lawrie W. Powell, Louise E. Ramm, Grant A. Ramm, John K. Olynyk

Summary: This study conducted a retrospective analysis of 112 HFE hemochromatosis patients and found that arthritis is strongly associated with advanced hepatic fibrosis. (This study conducted a retrospective analysis of 112 HFE hemochromatosis patients and found that arthritis is strongly associated with advanced hepatic fibrosis.)

MAYO CLINIC PROCEEDINGS (2022)

Article Respiratory System

Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators

Carla Colombo, Grant A. Ramm, Anders Lindblad, Fabiola Corti, Luigi Porcaro, Federico Alghisi, Irina Asherova, Helen Evans, Nataliya Kashirskaya, Elena Kondratyeva, Peter J. Lewindon, Isabelle de Monestrol, Mark Oliver, Chee Y. Ooi, Rita Padoan, Sahana Shankar, Gianfranco Alicandro

Summary: Cystic-fibrosis-related liver disease (CFLD) is a variable phenotype of CF. CFTR modulator therapies, elexacaftor, tezacaftor, and ivacaftor (ETI), and ivacaftor (IVA), are available for CF patients. Genetic eligibility evaluation showed that 13% of patients without CFLD and 11% of patients with severe CFLD are not eligible for ETI or IVA therapy. Ineligible patients cannot benefit from these new treatments.

JOURNAL OF CYSTIC FIBROSIS (2023)

Editorial Material Gastroenterology & Hepatology

Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver

Darrell H. G. Crawford, Grant A. Ramm, Kim R. Bridle, Amanda J. Nicoll, Martin B. Delatycki, John K. Olynyk

HEPATOLOGY INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: A multi-center study validated by liver biopsy

Shruti Sakhuja, Heather M. Staples, Charles G. Minard, Louise E. Ramm, Peter J. Lewindon, Grant A. Ramm, Daniel H. Leung

Summary: This study aimed to evaluate the clinical utility of lung function and liver biomarkers assessed years prior to liver biopsy-proven CFLD in predicting the risk of severe fibrosis development. The findings suggest that mild-moderate pulmonary dysfunction and higher liver biomarker indices at baseline may be associated with faster progression of CFLD.

LIVER INTERNATIONAL (2023)

Article Oncology

TWEAK/Fn14 Signalling Regulates the Tissue Microenvironment in Chronic Pancreatitis

N. Dianah B. Abu Bakar, Rodrigo Carlessi, Jully Gogoi-Tiwari, Julia Kohn-Gaone, Vincent Williams, Marco Falasca, John K. Olynyk, Grant A. Ramm, Janina E. E. Tirnitz-Parker

Summary: The TWEAK/Fn14 signalling pathway plays a crucial role in tissue injury and regeneration, and its involvement in pancreatic injury and cancer is not well understood. This study demonstrates that TWEAK/Fn14 signalling is important in the establishment and progression of chronic pancreatitis, increasing the risk of pancreatic cancer. The findings suggest the TWEAK/Fn14 pathway as a potential therapeutic target.

CANCERS (2023)

Article Genetics & Heredity

Height of non-Hispanic white adults with homeostatic iron regulator HFE genotypes p.C282Y/p.C282Y and wt/wt

James C. Barton, J. Clayborn Barton, Ronald T. Acton

Summary: This study aimed to evaluate the height of white adults with hemochromatosis. The results showed that there was no association between HFE genotype and height in men, while women with the p.C282Y/p.C282Y genotype had a greater height. No independent association was found between HFE genotype and height in both men and women.

MOLECULAR GENETICS & GENOMIC MEDICINE (2023)

Article Medicine, General & Internal

Polycythemia Rubra Vera and Sporadic Bilateral Renal Angiomyolipomas: A Case Report

James C. Barton, Barrett P. Cary, Robert M. Frederickson

Summary: This article reports a case of a 71-year-old woman who was diagnosed with polycythemia rubra vera and asymptomatic sporadic bilateral renal angiomyolipomas. Phlebotomy and hydroxyurea were used for the treatment of polycythemia rubra vera, while surveillance was conducted for the renal angiomyolipomas.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Article Gastroenterology & Hepatology

Trajectories of patients relisted for liver transplantation

Fakhar Ali Qazi Arisar, Rhea Varghese, Shiyi Chen, Wei Xu, Markus Selzner, Ian Mcgilvray, Blayne Sayed, Trevor Reichman, Chaya Shwaartz, Mark Cattral, Anand Ghanekar, Gonzalo Sapisochin, Elmar Jaeckel, Cynthia Tsien, Nazia Selzner, Leslie Lilly, Mamatha Bhat

Summary: Recurrent cirrhosis complicates a significant percentage of liver transplants and may require re-transplantation. This study examined the trajectories of relisted versus primary listed patients on the waitlist and assessed their overall survival and cumulative incidence of transplant.

ANNALS OF HEPATOLOGY (2024)

Article Gastroenterology & Hepatology

Alcohol-associated liver disease: Epidemiology and management

Helena Hernandez-Evole, Natalia Jimenez-Esquivel, Elisa Pose, Ram on Bataller

Summary: Alcohol is the leading cause of preventable morbidity and mortality worldwide, and the most frequent cause of liver disease. Alcohol-associated liver disease has a complex pathogenesis, with unknown precise mechanisms. Currently, there are no targeted therapies to interfere with the disease's progression, making alcohol abstinence the most effective measure to improve prognosis in patients with this disease.

ANNALS OF HEPATOLOGY (2024)

Letter Gastroenterology & Hepatology

Schistosomiasis: A neglected cause of liver disease in the Philippines

Alexander M. Sy

ANNALS OF HEPATOLOGY (2024)

Letter Gastroenterology & Hepatology

Balancing perspectives: Schistosomiasis in the liver disease landscape of the Philippines

Eric David Ornos, Janus P. Ong

ANNALS OF HEPATOLOGY (2024)

Review Gastroenterology & Hepatology

A clinical review of congenital hepatic fibrosis diagnosed in adulthood: presentation, complications, and outcomes

Lauren Loeb, Jason Lewis, Zhongwei Peng, Michael G. Heckman, Raouf Nakhleh, Andrew P. Keaveny

Summary: Congenital hepatic fibrosis (CHF) is a rare condition characterized by biliary tract changes and liver fibrosis. This study reviewed the medical records of 24 adult patients with CHF and found that renal cysts, splenomegaly, and a cirrhotic-appearing liver were the most common imaging findings. The most common liver-related complications were cholangitis, varices, and hepatic encephalopathy. Liver transplantation may be required for patients with decompensated disease.

ANNALS OF HEPATOLOGY (2024)